Biopharma cuts at manufacturing plants expected to affect 4,000+

As companies invest billions of dollars to reshore manufacturing, 10 biotech and pharma businesses are reportedly trimming staff at manufacturing locations in 2026 or the coming years, with BioNTech having the deepest cuts.

Rhyter Times aggregates short excerpts. The full story is reported by Biospace.

Read the full story at Biospace →